- Главная
- Аналитика приложений
- Anticoagulation Manager
- Anticoagulation Manager Vs. AnticoagEvaluator
Anticoagulation Manager против AnticoagEvaluator Использование & Stats
The Anticoagulation Manager is a mobile application developed through the collaborative efforts of the CDC and the Georgia Institute of Technology. Since the determination of the correct type and dose of anticoagulant drugs can be challenging, this application is a resource for clinicians to appropriately order laboratory testing and choose anticoagulant drugs for the various indications. It gives clinicians evidence-based, accessible, and accurate information when prescribing anticoagulants to prevent and/or treat abnormal clotting states.
- Apple App Store
- Бесплатный
- Медицина
Рейтинг магазина
- -
Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
- Apple App Store
- Бесплатный
- Медицина
Рейтинг магазина
- -
Anticoagulation Manager vs. AnticoagEvaluator ranking comparison
Compare Anticoagulation Manager ranking trend in the past 28 days vs. AnticoagEvaluator
Rank
Нет данных
Рейтинг Anticoagulation Manager против AnticoagEvaluator в сравнении по странам
Сравните динамику рейтинга Anticoagulation Manager за последние 28 дней с динамикой рейтинга AnticoagEvaluator.
Нет данных для отображения
Сравните данные с любым сайтом, воспользовавшись бесплатной пробной версией
Anticoagulation Manager VS.
AnticoagEvaluator
декабрь 23, 2024